NCT00325351View on ClinicalTrials.gov

ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 24, 2006

Primary Completion Date

July 8, 2008

Study Completion Date

March 25, 2009

Conditions
Ovarian Neoplasms
Interventions
DRUG

Sagopilone (ZK 219477) + carboplatin

Chemotherapy for recurrent ovarian cancer

Trial Locations (16)

21204

Baltimore

24014

Roanoke

27157

Winston-Salem

31404

Savannah

37920

Knoxville

44109

Cleveland

46617

South Bend

72205

Little Rock

73104

Oklahoma City

85724

Tucson

87131

Albuquerque

92093

La Jolla

92121

San Diego

93309

Bakersfield

T2N 4N2

Calgary

M4N 3M5

Toronto

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY